Ichimori K, Ottesen EA

Idioma: Ingles.
Referencias bibliográficas: 13
Paginas: 146-149
Archivo PDF: 224.95 Kb.

RESUMEN

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. World Health Organization. Global Programme to Eliminate Lymphatic Filariasis. Progress report 2000-2009 and strategic plan 2010-2020: halfway towards eliminating lymphatic filariasis. Geneva: World Health Organization; 2010. Contract No.: WHO/HTM/NTD/PCT/2010.6.

2. Ottesen EA. Lymphatic filariasis: treatment, control and elimination. Adv Parasitol 2006;61:395-441.

3. Witt C, Ottesen EA. Lymphatic filariasis: an infection of childhood. Trop Med Int Health 2001;6:582-606.

4. Ottesen EA, Hooper PJ, Bradley M, Biswas G. The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis 2008;2:e317.

5. Chu BK, Hooper PJ, Bradley MH, McFarland DA, Ottesen EA. The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007). PLoS Negl Trop Dis 2010;4:e708.

6. Gyapong JO, Kumaraswami V, Biswas G, Ottesen EA. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opin Pharmacother 2005;6:179-200.

7. Weil GJ, Lammie PJ, Weiss N. The ICT filariasis test: a rapidformat antigen test for diagnosis of bancroftian filariasis. Parasitol Today 1997;13:401-404.

8. Gustavsen KM, Bradley MH, Wright AL. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis. Ann Trop Med Parasitol 2009;103(suppl1):S11-S15.

9. Eisai Public Relations Department. Eisai to provide medicine to help World Health Organization (WHO) combat lymphatic filariasis epidemic; 2010. Available at: http://www.eisai.co.jp/enews/enews201066.html.

10. Fenwick A, Molyneux D, Nantulya V. Achieving the millennium development goals. Lancet 2005;365:1029-1030.

11. Dreyer G, Addiss D, Dreyer P, Noroes J. Basic lymphedema management: treatment and prevention of problems associated with lymphatic filariasis. Hollis, NH: Hollis Publishing Company; 2002.

12. Brantus P. Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis. Ann Trop Med Parasitol 2009;103(suppl 1):S5-S10.

13. World Health Organization. Monitoring and epidemiological assessment of mass drug administration in the programme to eliminate lymphatic filariasis. Geneva: World Health Organization. 2011, in press. Contract No.: WHO/HTM/NTD/2011.xx.